Novel glyproline GZK-111 with neuropsychotropic activity

Article Properties
Abstract
Cite
Koliasnikova, K. N., et al. “Novel Glyproline GZK-111 With Neuropsychotropic Activity”. Pharmacokinetics and Pharmacodynamics, no. 4, 2022, pp. 18-23, https://doi.org/10.37489/2587-7836-2021-4-18-23.
Koliasnikova, K. N., Alyaeva, A. G., & Kuznetsova, E. A. (2022). Novel glyproline GZK-111 with neuropsychotropic activity. Pharmacokinetics and Pharmacodynamics, 4, 18-23. https://doi.org/10.37489/2587-7836-2021-4-18-23
Koliasnikova KN, Alyaeva AG, Kuznetsova EA. Novel glyproline GZK-111 with neuropsychotropic activity. Pharmacokinetics and Pharmacodynamics. 2022;(4):18-23.
Journal Category
Medicine
Pharmacy and materia medica
Refrences
Title Journal Journal Categories Citations Publication Date
The effects of cycloprolylglycine and its analogues on brain monoaminergic systems in BALB/c mice Pharmacokinetics and Pharmacodynamics
  • Medicine: Pharmacy and materia medica
 3 2020
Effects of Original Compounds GSB-106, GML-3, and GZK-111 in an Experimental Lipopolysaccharide-Induced Anhedonia Model Pharmaceutical Chemistry Journal
  • Medicine: Therapeutics. Pharmacology
  • Medicine: Therapeutics. Pharmacology
  • Medicine: Public aspects of medicine: Toxicology. Poisons
 6 2021
10.1023/A:1016293904149
702. Polypeptides. Part IV. The self-condensation of the esters of some peptides of glycine and proline J. Chem. Soc. 34 1956
Neuropeptide Cycloprolylglycine Exhibits Neuroprotective Activity after Systemic Administration to Rats with Modeled Incomplete Global Ischemia and in In Vitro Modeled Glutamate Neurotoxicity Bulletin of Experimental Biology and Medicine
  • Medicine: Medicine (General)
  • Medicine: Medicine (General)
 11 2016